CTIM-35. A PHASE II STUDY OF GITR AGONIST INCAGN01876 AND PD-1 INHIBITOR RETIFANLIMAB IN COMBINATION WITH STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA by Bagley, Stephen, Shabason, Jacob, Mathew, Divij, Kothari, Shawn, Oldridge, Derek, Desai, Arati, Lustig, Robert, Kurtz, Goldie, Alonso-Basanta, Michelle, Chen, Kan, Long, Qi, Harsch, Jessica, Salman, Muhammad, Fernandez, Peter, Monsour, Maikel, Prior, Timothy, Maloney, Eileen, MacMurtrie, Eileen, Angeloni, Natalie, O’Neill, Meghan, Albright, Karen, Caturla, Maria, Ignatowski, Melissa, Frangos, Suzanne, Blessing, Caroline, Phillips, Richard, Nabavizadeh, Ali, Mohan, Suyash, Nasrallah, MacLean, Jackson, Christina, Brem, Steven, Amankulor, Nduka, Binder, Zev, O’Rourke, Donald, Wherry, E John

Get full text